These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration. Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]
6. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Foster RD; Pham S; Li S; Aitouche A Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367 [TBL] [Abstract][Full Text] [Related]
8. [The future of immunotherapy for composite tissues allotransplantation]. Petit F Ann Chir Plast Esthet; 2007 Oct; 52(5):502-8. PubMed ID: 17651884 [TBL] [Abstract][Full Text] [Related]
9. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. Shirasugi N; Adams AB; Durham MM; Lukacher AE; Xu H; Rees P; Cowan SR; Williams MA; Pearson TC; Larsen CP J Immunol; 2002 Sep; 169(5):2677-84. PubMed ID: 12193741 [TBL] [Abstract][Full Text] [Related]
10. Induction of tolerance of vascularized composite allografts. Leonard DA; Cetrulo CL; McGrouther DA; Sachs DH Transplantation; 2013 Feb; 95(3):403-9. PubMed ID: 23114532 [TBL] [Abstract][Full Text] [Related]
11. Donor-specific tolerance induction in composite tissue allografts. Foster RD; Fan L; Neipp M; Kaufman C; McCalmont T; Ascher N; Ildstad S; Anthony JP; Niepp M Am J Surg; 1998 Nov; 176(5):418-21. PubMed ID: 9874425 [TBL] [Abstract][Full Text] [Related]
12. Novel immunosuppressive strategies for composite tissue allografts. Gupta A; Kumer S; Kaplan B Curr Opin Organ Transplant; 2014 Dec; 19(6):552-7. PubMed ID: 25333828 [TBL] [Abstract][Full Text] [Related]
13. Potential of costimulation-based therapies for composite tissue allotransplantation. Elster EA; Blair PJ; Kirk AD Microsurgery; 2000; 20(8):430-4. PubMed ID: 11150995 [TBL] [Abstract][Full Text] [Related]
14. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts. Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021 [TBL] [Abstract][Full Text] [Related]
15. Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. Wu S; Xu H; Ravindra K; Ildstad ST Transplant Proc; 2009 Mar; 41(2):463-5. PubMed ID: 19328904 [TBL] [Abstract][Full Text] [Related]
16. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers. Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439 [TBL] [Abstract][Full Text] [Related]
17. The beginning of clinical tolerance in solid organ allografts. Monaco AP Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922 [TBL] [Abstract][Full Text] [Related]
18. Past, present, and future prospects for inducing donor-specific transplantation tolerance for composite tissue allotransplantation. Bozulic LD; Breidenbach WC; Ildstad ST Semin Plast Surg; 2007 Nov; 21(4):213-25. PubMed ID: 20567674 [TBL] [Abstract][Full Text] [Related]
19. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols. Suthanthiran M; Haschemeyer RH; Riggio RR; Adubor C; Friedman GS; Cheigh JS; Wang JC; Fotino M; Stubenbord WT; Saal SD Transplantation; 1993 May; 55(5):1008-13. PubMed ID: 8497873 [TBL] [Abstract][Full Text] [Related]
20. Adipose-derived stromal cell therapy combined with a short course nonmyeloablative conditioning promotes long-term graft tolerance in vascularized composite allotransplantation. Schweizer R; Taddeo A; Waldner M; Klein HJ; Fuchs N; Kamat P; Targosinski S; Barth AA; Drach MC; Gorantla VS; Cinelli P; Plock JA Am J Transplant; 2020 May; 20(5):1272-1284. PubMed ID: 31774619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]